The publication of the Malaria Eradication Research Agenda (malERA) established the global R&D agenda for malaria eradication.
The preliminary results of the Phase III clinical trial show that the leading malaria vaccine candidate RTS,S provides significant protection against clinical and severe malaria in African children.
The 7th European Congress of Tropical Medicine and International Health brought together more than 1,600 global health experts in Barcelona.
CRESIB’s scientific production reached its peak in 2011: 166 scientific articles published and a 157% rise in the total Impact Factor.
CRESIB is leading research at ISGlobal, aiming to extend the value chain from research to knowledge creation, management, transmission and application in the field.